Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors

Title
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 127, Issue 6, Pages 2176-2191
Publisher
American Society for Clinical Investigation
Online
2017-04-24
DOI
10.1172/jci87624

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now